Peak6 Investments LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $4.01 Million - $5.19 Million	100,000 New	100,000 $4.01 Million
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $173,560 - $206,520	4,000 New	4,000 $202,000
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $1.41 Million - $1.87 Million	38,500 New	38,500 $1.7 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $648,960 - $989,040	15,600 Added 82.54%	34,500 $1.63 Million
Q3 2019 Nov 08, 2019	SELL	$59.06 - $72.15 $720,532 - $880,230	-12,200 Reduced 39.23%	18,900 $1.13 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.74 Million - $3.81 Million	-44,200 Reduced 58.7%	31,100 $2 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $3.37 Million - $5.16 Million	63,600 Added 543.59%	75,300 $6.11 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $501,696 - $628,290	11,700 New	11,700 $603,000

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.